19.07.2021 16:30
TargImmune Therapeutics AG, focused on the development of new medicines through the use of novel targeted immunotherapies, has closed a financing round expanding the company’s cash position into the clinical development of its lead candidate. In addition, Peter Braun, who has extensive experience in the healthcare industry, has been appointed Chief Executive Officer (CEO), effective August 16, 2021.